The study team characterised resting‑state functional connectivity (FC) of small brainstem nuclei in healthy older adults. They recruited participants aged 60–80 years and acquired brainstem‑optimised fMRI. Age correlated positively with FC of the locus coeruleus (LC) and dorsal raphe nucleus (DRN) to the precentral and postcentral gyri. Age also correlated with FC of the periaqueductal gray (PAG) to temporal and supramarginal gyri and to the planum temporale. The authors reported these baseline correlations at p<0.0063.
Data indicated that FC of PAG with the precuneus cortex and cingulate gyrus related to measures of cognitive status and mood. Perceived stress levels were associated with connectivity between the nucleus tractus solitarius (NTS) and occipital cortex, as well as angular and temporal gyri. The cohort‑level associations were reported by the authors as statistically significant at the thresholds noted in the source.
The study team observed differences in DRN functional connectivity between men and women at baseline. The source reported this sex difference as part of the cross‑sectional analysis, with significance reported alongside the other baseline FC findings (all p<0.0063).
Investigators ran a randomised, double‑blind, placebo‑controlled trial of a six‑week probiotic intervention using Lacticaseibacillus rhamnosus HN001. The probiotic was delivered in two formulations: non‑encapsulated and microencapsulated. Brainstem‑focused MRI was performed before and after the intervention period. The source states the trial was registered (NCT05801042) and that ethical approval was obtained from the Swedish Ethical Review Authorities (registration and amendment numbers provided in the manuscript). The authors disclosed provision of product and technical support by AnaBio Technologies, and funding from AnaBio Technologies and the Swedish Knowledge Foundation.
Following the intervention, investigators reported a significant time*group interaction and a main time effect for FC of the LC and the ventral tegmental area (VTA). Specifically, the authors indicated that FC changes involving these nuclei and occipital pole/cortex and cerebellum were observed. The reported significance thresholds for post‑intervention effects were p<0.0056 according to the source.
Within the non‑encapsulated probiotic arm, the study team observed several within‑group changes. These included altered LC and VTA connectivity with the occipital pole/cortex and cerebellum, and expanded LC connectivity with precentral/postcentral gyri, superior parietal lobule, insular/opercular cortex, putamen and planum polare. Despite within‑group shifts, the authors reported no statistically significant between‑group differences after correction (all p<0.0056). The source did not provide additional mechanistic or causal data explaining the connectivity changes beyond the reported imaging associations.
The authors declared that AnaBio Technologies developed, manufactured and provided the probiotic and placebo products and supplied technical support for the formulations. The manuscript states that the sponsor did not influence the analyses or interpretation. Funding sources listed in the source include AnaBio Technologies and the Swedish Knowledge Foundation. The dataset is pseudonymised; however, Swedish ethics regulations restrict unrestricted raw data sharing. The authors noted that requests for data must follow the institutional process and undergo a confidentiality assessment (contact provided in the source).
This report is a medRxiv preprint and has not been peer reviewed; the authors explicitly noted that the findings should not be used to guide clinical practice. The source documents restricted data access owing to national ethics rules, and it reports within‑group connectivity changes without between‑group differences, which limits interpretation of probiotic efficacy at the group level. The manuscript did not report long‑term follow‑up beyond the six‑week intervention or mechanistic proof linking microbial changes to the observed FC shifts. Open questions that remain in the source include whether the observed brainstem FC associations reflect causal microbiome‑driven neural modulation, whether effects differ by formulation reliably, and whether findings generalise beyond the studied age range and sample. Trial registration: NCT05801042. Ethical oversight: Swedish Ethical Review Authorities (approval and amendment numbers provided in the source).